Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
7 hedge funds and large institutions have $965K invested in Novo Integrated Sciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
69% more capital invested
Capital invested by funds: $570K → $965K (+$395K)
13% less funds holding
Funds holding: 8 → 7 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$37.4K |
| 2 |
BlackRock
New York
|
+$21K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.56K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.36K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$17 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$19K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $591K | – | – | – |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $200K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $58K | +$1.36K | +82 | +3% |
|
|
4
BlackRock
New York
| $54K | +$21K | +1,264 | +114% |
|
|
CH
5
CVI Holdings
Wilmington,
Delaware
| $52K | +$37.4K | +2,249 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $10K | +$1.56K | +94 | +28% |
|
|
7
Renaissance Technologies
New York
| – | -$19K | -1,380 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$18K | -1,318 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | +$17 | +1 | +20% |
|
NVOS Hedge Fund Activity: Q1 2022 in Review
7 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q1 2022, worth a combined $965K — up 69% from $570K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NVOS and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.
The largest buyer was CVI Holdings, opening a new position worth an estimated $37.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $19K sold.
- 7 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q1 2022, down from 8 in Q4 2021.
- Funds reported $965K of Novo Integrated Sciences, Inc. Common Stock stock for Q1 2022, up 69% quarter-over-quarter.
- 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q1 2022 and 2 closed out, a net change of -1 holder.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q1 2022 was CVI Holdings, an estimated $37.4K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q1 2022 was Renaissance Technologies, an estimated $19K sold.
Based on aggregated 13F filings for Q1 2022.